English | Español

Biospace
Patient Daily | Mar 17, 2026

BridgeBio reports positive Phase 3 results for limb-girdle muscular dystrophy drug
Patient Daily | Mar 17, 2026

Eli Lilly warns of safety risks in compounded tirzepatide formulations
Patient Daily | Mar 17, 2026

Biogen, Sarepta, and Edgewise present new data at Muscular Dystrophy Association 2026 conference
Patient Daily | Mar 17, 2026

Los Angeles aims to become a leading global life sciences hub
Patient Daily | Mar 17, 2026

Industry questions FDA’s data-sharing guidance for cell and gene therapy sector
Patient Daily | Mar 17, 2026

Biopharma job postings rise in February, marking first annual increase since 2022
Patient Daily | Mar 17, 2026

Solid Biosciences reports new data for Duchenne gene therapy in Phase 1/2 trial
Patient Daily | Mar 17, 2026

Evaluate projects rare disease drug sales to surpass $400 billion by 2032

Trending
+ Marketing
A. K. Abreu | Jun 9, 2026

Patient in 5.0 Google review: Gulf Coast Breathe Free Sinus & Allergy Centers ‘changed my life’
Patient Daily | Jun 5, 2026

National Breathe Free donates $175,000 to support shelter for Tampa Bay families
+ Regulatory
Patient Daily News Service | Jun 9, 2026

New colon cancer blood test wins Medicare coverage, but trails stool-based screening in detecting precancerous lesions
+ Pharmaceuticals
Patient Daily | Jun 8, 2026

FDA rare disease framework faces uncertainty after leadership departures